MEDICAL PRODUCTS — TURKEY-ORIGIN SOURCING
Medical Products Sourcing from Turkey
Independent buyer-side procurement governance for international buyers sourcing medical products and devices from Turkey. Structure your sourcing before supplier commitment. No trading. No supplier representation. No commissions.
TURKEY’S POSITION IN THIS SECTOR
Why buyers source medical products from Turkey.
Turkey has a growing medical device and healthcare products manufacturing base with documented export activity to EU, MENA, and USA markets across disposables, diagnostic equipment, orthopaedic products, surgical instruments, and hospital supplies. The sector requires the highest level of compliance verification among all sourcing categories. Understanding both production capabilities and sector-specific regulatory risks is essential before any sourcing engagement begins.
Manufacturing Strengths
- Established production capability across medical disposables, surgical instruments, orthopaedic products, hospital furniture, and diagnostic equipment categories
- Manufacturers with documented EU and MENA export activity exist across multiple medical product categories
- Some manufacturers hold ISO 13485 quality management system certification and EU MDR Notified Body involvement
- Cost-competitive production capability for standard medical disposables and hospital supply categories
- Geographic proximity supports competitive logistics for EU and MENA buyers
- Private label and OEM production available where quality management systems and regulatory compliance are independently confirmed
Common Buyer Challenges
- ISO 13485 certificates frequently misrepresented in scope — the certificate may not cover the specific product category or production process being sourced
- EU MDR 2017/745 Notified Body certificate validity and scope not confirmed — MDD-era certificates must not be accepted at face value; transitional status requires independent confirmation
- Manufacturer vs trader distinction particularly difficult to establish in medical products — trading intermediaries present with manufacturer-level compliance documentation
- FDA QMSR requirements not confirmed for USA-bound sourcing engagements
- Sterilisation process validation documentation rarely confirmed before commercial engagement begins
- Labelling compliance for destination market language and regulatory requirements not confirmed before order placement
“In medical sourcing, an expired certificate is a patient safety risk.”
In Turkey-origin medical products sourcing, ISO 13485 certification and EU MDR Notified Body involvement are the minimum compliance entry points — not evidence of full regulatory readiness. Certificate scope, Notified Body certificate validity, and manufacturer identity all require independent confirmation before any medical product sourcing engagement progresses. Compliance gaps in this sector carry consequences beyond commercial risk.
REQUIREMENTS BY TARGET MARKET
Turkey does not change. Your target market does.
Medical product compliance requirements vary significantly by destination market and device classification. EU MDR, US FDA, and MENA import requirements each impose different obligations. These requirements must be fully mapped before supplier shortlisting begins.
European Union
- EU MDR 2017/745 — mandatory for medical devices; MDD-era certificates must not be accepted at face value
- ISO 13485:2016 — quality management system; scope must cover the specific product category
- Notified Body involvement required for Class IIa, IIb, and III devices
- EU Authorised Representative required for non-EU manufacturers
- CE marking under MDR framework with current, traceable certificate
- EUDAMED obligations where applicable and operational
United States
- FDA QMSR — Quality Management System Regulation, aligned with ISO 13485, effective February 2, 2026
- 510(k) clearance, PMA approval, or De Novo classification depending on device class
- FDA facility registration and device listing for US-distributed products
- US Agent requirement for foreign manufacturers
- Labelling compliance with FDA requirements including intended use, indications, and warnings
- Import documentation and Importer of Record requirements
Middle East & North Africa
- Country-specific medical device registration — requirements vary significantly by market
- SFDA registration for Saudi Arabia; DOH and MOHAP for UAE
- ISO 13485 certification typically required as registration baseline
- CE marking under EU MDR often accepted as technical documentation reference
- Arabic labelling and country-specific IFU requirements where applicable
- Health authority import permit requirements vary by country and device category
Balkans Region
- EU MDR alignment applicable in EU-candidate markets
- CE marking under MDR framework where EU alignment applies
- ISO 13485 certification as quality management baseline
- Import documentation and conformity certificates
- Country-specific medical device registration where applicable
- Technical documentation in relevant language where required
COMPLIANCE TRAPS
The two most critical compliance failures in Turkey-origin medical product sourcing.
These are recurring sourcing risks in electrical and lighting projects. Most appear after supplier selection rather than before it, and both can be reduced through structured verification before commercial engagement begins.
ISO 13485 scope mismatch — certificate does not cover the specific product
A Turkish medical product supplier presents an ISO 13485 certificate. The certificate is scoped to a different product category, a different production process, or a different site than the one that will produce the goods being sourced. ISO 13485 certification is scoped to specific product categories and manufacturing processes — a certificate covering one product type does not extend to another. Scope confirmation against the specific product category, production site, and contracting legal entity must be completed before any medical product sourcing engagement progresses.
Expired or MDD-era Notified Body certificate — no longer valid for EU MDR
A supplier presents a Notified Body certificate for EU market access. The certificate was issued under the Medical Devices Directive (MDD 93/42/EEC). MDD-era certificates should not be accepted at face value — their transitional validity, device scope, and MDR transition conditions must be independently confirmed before EU-bound sourcing progresses. Alternatively, an MDR certificate may have lapsed or the Notified Body may have had its designation suspended. EU MDR 2017/745 Notified Body certificate validity, scope, and Notified Body designation status must be independently confirmed before any EU-bound medical product sourcing begins.
WHERE SOURCING FAILS IN THIS CATEGORY
What buyers sourcing medical products from Turkey actually face.
Medical product sourcing failures in Turkey carry consequences beyond commercial risk. They occur when certification scope, manufacturer identity, and regulatory framework compliance are assumed rather than independently verified before engagement begins.
Certification scope not confirmed against the specific product
Buyers accept ISO 13485 certification as evidence of quality management compliance without confirming the scope against the specific product, production process, and site. A certificate that exists for a different product category does not confirm compliance for the product being sourced. Scope confirmation is the first verification requirement — not an optional step.
Trader presenting as manufacturer with regulatory documentation
Turkey-origin medical product trading intermediaries frequently present with ISO 13485 certificates, CE marking documentation, and MDR involvement claims that belong to the manufacturers they source from. The contracting entity and the manufacturing entity with regulatory authorisation must be confirmed as the same. In medical products, this distinction carries regulatory and patient safety implications — not just commercial risk.
MDD certificate presented as valid EU MDR compliance
EU MDR 2017/745 replaced MDD 93/42/EEC and AIMD 90/385/EEC. MDD-era certificates should not be accepted at face value — transitional validity, device scope, and MDR transition conditions must be independently confirmed. A supplier presenting an MDD-era Notified Body certificate as evidence of EU market compliance is presenting documentation whose current validity requires independent verification. EU MDR Notified Body certificate status must be confirmed before any EU-bound medical product order is placed.
Sterilisation and labelling compliance not confirmed before commitment
For sterile medical products, sterilisation process validation documentation is rarely confirmed before commercial engagement begins. For all medical products, destination market labelling requirements — including language, symbols, and regulatory information — are frequently not confirmed before order placement. Both gaps create regulatory exposure that surfaces at import or distribution stage — after commercial commitment has been made.
COMPLIANCE & CERTIFICATION MAP
What medical product buyers need confirmed before supplier engagement.
The certifications and regulatory requirements below are the most commonly required — and the most frequently misrepresented — in Turkey-origin medical product sourcing. Requirements vary by device classification and destination market. Each must be confirmed before commercial engagement begins.
| Certification / Requirement | What it covers | Common gap in Turkey sourcing | Status |
|---|---|---|---|
| ISO 13485:2016 Quality Management System for medical devices | Quality management system framework specific to medical device design, production, installation, and servicing — required by EU MDR and most destination market regulatory frameworks | Certificate scoped to a different product category, process, or site than the one producing the goods being sourced; certificate held by a different legal entity than the contracting supplier | Typically required — all markets |
| EU MDR 2017/745 EU Medical Device Regulation | Mandatory regulatory framework for medical devices placed on the EU market — replaced MDD 93/42/EEC; requires Notified Body involvement for Class IIa, IIb, and III devices | MDD-era certificates presented as valid EU compliance; Notified Body certificate lapsed or Notified Body designation suspended; EU Authorised Representative not confirmed | Required — EU market |
| FDA QMSR US Quality Management System Regulation, effective February 2, 2026 | Updated US FDA quality management system regulation aligned with ISO 13485 — replaces 21 CFR Part 820 QSR for medical devices distributed in the USA | Suppliers may not be aware of QMSR transition requirements; compliance position not confirmed for USA-bound sourcing engagements initiated before transition deadline | Verify for USA market |
| CE Marking under MDR EU conformity marking | Confirms conformity with EU MDR requirements for the specific device — CE marking under MDD should not be accepted at face value without confirming transitional status and MDR applicability | CE marking present under superseded MDD framework; Notified Body certificate not current or not traceable to the specific device and contracting entity | Verify MDR compliance status |
| GMP Compliance Good Manufacturing Practice | Manufacturing practice standards covering facility, process, documentation, and quality controls for medical product production | GMP compliance assumed from ISO 13485 certification; actual production facility GMP compliance not independently confirmed | Verify facility-level compliance |
| Sterilisation Validation For sterile medical products | Documented validation confirming that the sterilisation process consistently achieves the required sterility assurance level for the specific product | Sterilisation validation documentation not requested or reviewed before commercial engagement; process validation not confirmed for the specific product configuration | Verify for sterile products |
KEY VERIFICATION AREAS
What we verify in medical product sourcing.
These are the specific verification points applied in every medical product sourcing engagement. Each area addresses a known structural gap in Turkey-origin medical supply chains. In this sector, verification is not optional — it is the minimum standard before any supplier advances to the RFQ stage.
ISO 13485 scope and facility confirmation
Certificate scope confirmed against the specific product category, production process, and manufacturing site — not accepted as general quality management evidence without scope review.
EU MDR Notified Body certificate validity
Notified Body certificate confirmed as issued under EU MDR 2017/745, current, and traceable to the contracting legal entity and specific device — including Notified Body designation status.
Manufacturer vs trader classification
Turkish Trade Registry review and production facility confirmation applied to establish whether the contracting entity is the regulated manufacturer or a trading intermediary presenting with manufacturer-level documentation.
Export activity and counterparty clarity
Export history confirmed for the contracting legal entity to the relevant destination market — not assumed from group-level claims or platform listings.
EU Authorised Representative confirmation
For EU-bound medical device sourcing, EU Authorised Representative arrangement confirmed as in place for the contracting manufacturer before any EU-bound engagement progresses.
GMP and sterilisation documentation readiness
GMP compliance at facility level and sterilisation process validation documentation availability confirmed before RFQ — particularly for sterile device categories.
WHAT YOU RECEIVE
Structured outputs at the end of each engagement stage.
Every medical product sourcing engagement produces documented outputs at each stage. These are not verbal assessments — they are structured deliverables that inform your sourcing decisions before any supplier advances to commercial engagement.
Supplier validation matrix
Structured comparison of assessed suppliers across registry status, ISO 13485 scope, MDR Notified Body certificate status, export activity, and manufacturer identity confirmation.
ISO 13485 scope and site review
Certificate scope confirmed against the specific product category, production process, and site — not accepted at face value from the supplier.
MDR Notified Body certificate status report
EU MDR 2017/745 Notified Body certificate validity, scope, and Notified Body designation status confirmed for each shortlisted supplier and device category.
Manufacturer / trader classification
Each assessed supplier classified as regulated manufacturer or trading intermediary based on registry review, production facility confirmation, and regulatory documentation ownership.
Compliance documentation risk summary
ISO 13485 scope, MDR Notified Body, GMP, sterilisation, and destination market regulatory gaps identified for each shortlisted supplier before commercial engagement begins.
Structured sourcing decision
Each assessed supplier receives a clear governance outcome before any commercial commitment is made.
SCOPE BOUNDARIES
What this engagement does not cover.
Clarity on scope boundaries is part of the governance structure. In medical product sourcing, scope boundaries are particularly important. The following activities are outside the scope of Hana Solution’s medical product sourcing engagement.
Issuing regulatory certifications or approvals
Hana Solution does not issue ISO 13485 certificates, MDR Notified Body certificates, FDA clearances, or any regulatory approval. These require accredited certification bodies, Notified Bodies, or regulatory authorities.
Acting as EU Authorised Representative
Hana Solution does not act as the EU Authorised Representative for any medical device manufacturer. This legal responsibility requires a qualified entity established within the EU under EU MDR requirements.
Acting as US Agent for FDA purposes
Hana Solution does not act as the US Agent for any Turkish medical device manufacturer for FDA registration or compliance purposes. This requires a qualified person or entity established in the USA.
Providing clinical or patient safety assessment
Compliance documentation screening identifies visible regulatory gaps. It does not constitute clinical evaluation, patient safety assessment, or a guarantee of device performance or safety for any specific application.
Representing or promoting suppliers
Hana Solution operates exclusively on the buyer side. No supplier is represented, promoted, or recommended. Supplier selection remains the buyer’s decision at all stages.
Trading or purchasing medical products
Hana Solution does not buy, sell, trade, or hold stock in any medical products or devices. All commercial transactions remain between the buyer and the verified supplier. No commissions or mark-ups are applied.
HOW HANA SOLUTION WORKS IN THIS SECTOR
Governance applied to medical product sourcing from Turkey.
The same six-stage governance sequence is applied to every engagement. In medical product sourcing, ISO 13485 scope confirmation, EU MDR Notified Body certificate validity, and manufacturer identity are the highest-priority validation steps — without exception.
Sourcing Direction & Strategy
Device classification, regulatory framework, and destination market compliance requirements defined before any supplier contact begins. Key validation: EU MDR device classification basis reviewed. Applicable regulatory framework considerations mapped. MENA country-specific registration requirements identified. Sterilisation requirements confirmed for sterile device categories.
Supplier Mapping & Shortlisting
Turkey-origin medical product manufacturers identified against defined criteria. Trading intermediaries are identified and separated from regulated manufacturers before shortlist formation. Key validation: entity classification confirmed — regulated manufacturer vs trading intermediary distinction applied before shortlist is formed.
Supplier Verification & Risk Screening Critical in this sector
Registry status, ISO 13485 scope, MDR Notified Body certificate validity, GMP compliance, and counterparty risk assessed for each shortlisted supplier. Key validation: ISO 13485 scope confirmed against specific product and site. MDR Notified Body certificate confirmed as current, MDR-era, and issued by a designated Notified Body. EU Authorised Representative status confirmed.
RFQ Governance & Quotation Analysis
Product specification and regulatory documentation requirements standardised across suppliers before RFQ is issued. Quotations normalised for scope and Incoterms before price assessment begins. Key validation: payment exposure and counterparty clarity assessed before negotiation.
Production Monitoring & Factory Visits
Production milestones tracked independently. GMP compliance and specification adherence monitored during active orders. Key validation: pre-shipment coordination checks agreed documentation set, visible specification alignment, labelling compliance, and supplier-provided regulatory documents before shipment.
Shipment Process Management
Export document set reviewed and destination import requirements confirmed before departure. Key validation: CE marking documentation, ISO 13485 certificate, sterilisation documentation where applicable, and destination regulatory compliance records confirmed in the shipment set before goods move.
RELATED SOLUTIONS
Each service is available as a standalone engagement.
You do not need to engage the full governance sequence. Start where your medical product sourcing situation requires.
FREQUENTLY ASKED QUESTIONS
What buyers ask before sourcing medical products from Turkey.
Are MDD certificates still valid for placing medical devices on the EU market?
MDD-era Notified Body certificates should not be accepted at face value for EU market access. EU MDR 2017/745 has replaced MDD 93/42/EEC as the primary framework for medical devices placed on the EU market. Transitional validity, device scope, and MDR transition conditions must be independently confirmed for any MDD-era certificate before EU-bound sourcing progresses. Where MDR 2017/745-compliant Notified Body involvement is confirmed, certificate validity, device scope, and Notified Body designation status should all be verified before any EU-bound sourcing engagement begins.
How do I confirm that a Turkish supplier’s ISO 13485 certificate covers my product?
ISO 13485 certification is scoped to specific product categories, manufacturing processes, and sites. A certificate may cover one type of medical product while excluding another. Confirming scope requires reviewing the certificate itself — specifically the scope statement — against the product category, production process, and manufacturing site relevant to your sourcing requirement. A certificate that covers surgical instruments does not automatically extend to diagnostic equipment or sterile disposables. Scope confirmation is part of the Supplier Verification stage in every medical product sourcing engagement.
What does FDA QMSR mean for medical products sourced from Turkey?
FDA QMSR (Quality Management System Regulation) aligns US medical device quality system requirements with ISO 13485. Effective February 2, 2026, it replaces 21 CFR Part 820. Turkish manufacturers exporting medical devices to the USA should confirm QMSR compliance readiness as part of their regulatory positioning for the US market. Buyers initiating USA-bound medical device sourcing from Turkey should confirm that shortlisted suppliers have assessed their QMSR compliance position before commercial engagement begins.
Can Hana Solution verify a Turkish medical product supplier we have already been working with?
Yes. Supplier Verification can be applied to existing relationships. ISO 13485 certificate validity, MDR Notified Body certificate status, GMP compliance, and regulatory authorisation can change over time. A supplier that held valid MDR Notified Body certification and confirmed ISO 13485 scope at the start of a commercial relationship may have experienced certificate lapses, Notified Body designation changes, or production scope modifications without proactive buyer notification. Verification confirms the current compliance position — not the position at first engagement.
Does Hana Solution represent or recommend specific medical product suppliers?
No. Hana Solution does not represent or promote suppliers. Supplier candidates are mapped and structurally assessed against defined regulatory criteria — but selection remains entirely the buyer’s decision after validation is complete. There are no commissions, supplier-side affiliations, or financial interests in which supplier is chosen. The engagement governs the process — it does not make commercial decisions on the buyer’s behalf.
START HERE
Start medical product sourcing with structure before negotiation.
Submit your sourcing requirements and target market. We establish the sourcing structure, map regulatory compliance requirements, and confirm whether a controlled engagement is the right next step — before supplier contact begins.